HBOT Conversations:

Join us for interviews with researchers, practitioners, industry experts, and patients to share their stories, successes, and expertise relative to hyperbaric oxygen therapy

Subscribe. Join the discussion. Share the hope.

 

 

 

Listen to or Watch the HBOT Conversations Podcast

Listen to the HBOT Converstations podcast by downloading it from your favorite podcasting platform or scroll down and watch an episode here on the HBOT News website:

Watch the HBOT Conversations Podcast

Laurie Anderson – Healing COVID with HBOT (Part 3)

Laurie Anderson – Healing COVID with HBOT (Part 3)

Laurie Anderson – Healing COVID with HBOT (Part 2)

Laurie Anderson – Healing COVID with HBOT (Part 2)

Laurie Anderson – Healing COVID with HBOT (Part 1)

Laurie Anderson – Healing COVID with HBOT (Part 1)

Tom Fox (Part 2)

Tom Fox (Part 2)

Tom Fox (Part 1)

Tom Fox (Part 1)

Elena Schertz & Tom Fox (Part 5)

Elena Schertz & Tom Fox (Part 5)

Elena Schertz & Tom Fox (Part 4)

Elena Schertz & Tom Fox (Part 4)

Elena Schertz & Tom Fox (Part 3)

Elena Schertz & Tom Fox (Part 3)

Elena Schertz & Tom Fox (Part 2)

Elena Schertz & Tom Fox (Part 2)

Elena Schertz & Tom Fox (Part 1)

Elena Schertz & Tom Fox (Part 1)

Dr. Jay Stevens  – Optimizing Health & Longevity

Dr. Jay Stevens – Optimizing Health & Longevity

Evan Fernandez – Warriors on the Water

Evan Fernandez – Warriors on the Water

Dr. Jay Stevens  – Head Injuries

Dr. Jay Stevens – Head Injuries

Jim Hooker – HBOT for Vets (Part 2)

Jim Hooker – HBOT for Vets (Part 2)

Jim Hooker – HBOT for Vets (Part 1)

Jim Hooker – HBOT for Vets (Part 1)

Dr. Hemal Mehta & Vibrant Health University

Dr. Hemal Mehta & Vibrant Health University

Dr. Jay Stevens  – Sports-Related Injuries & Performance Enhancement

Dr. Jay Stevens – Sports-Related Injuries & Performance Enhancement

Ernie Harrison: Veteran with PTSD & TBI

Ernie Harrison: Veteran with PTSD & TBI

Dr. Hemal Mehta & Regenerative Medicine

Dr. Hemal Mehta & Regenerative Medicine

Dr. Hemal Mehta & Fasting (Part 2)

Dr. Hemal Mehta & Fasting (Part 2)

Dr. Hemal Mehta & Fasting (Part 1)

Dr. Hemal Mehta & Fasting (Part 1)

Dr. Jay Stevens – “Learn The Right Fast”

Dr. Jay Stevens – “Learn The Right Fast”

Dr. Peter Canaday (Part 2)

Dr. Peter Canaday (Part 2)

Dr. Peter Canaday (Part 1)

Dr. Peter Canaday (Part 1)

Dr. Paul Harch & Viral / Bacterial Infections

Dr. Paul Harch & Viral / Bacterial Infections

Dr. Paul Harch & 8,101 Genes

Dr. Paul Harch & 8,101 Genes

Dr. Paul Harch & Autism

Dr. Paul Harch & Autism

Dr. Paul Harch & Strokes

Dr. Paul Harch & Strokes

Dr. Paul Harch & Birth Injuries/ Cerebral Palsy

Dr. Paul Harch & Birth Injuries/ Cerebral Palsy

Dr. Paul Harch & The Science Behind the Practice

Dr. Paul Harch & The Science Behind the Practice

Dr. Paul Harch & TBI

Dr. Paul Harch & TBI

Dr. Paul Harch & Thermal Burns

Dr. Paul Harch & Thermal Burns

Dr. Paul Harch & Inflammation

Dr. Paul Harch & Inflammation

Robert Beckman & TreatNow.org

Robert Beckman & TreatNow.org

Elena Schertz & Extivita RTP

Elena Schertz & Extivita RTP

Subscribe Now, It’s Free !

Name(Required)

Recent HBOT News

Hyperbaric oxygen therapy can improve post concussion syndrome years after mild traumatic brain injury – randomized prospective trial.

Traumatic brain injury (TBI) is the leading cause of death and disability in the US. Approximately 70-90% of the TBI cases are classified as mild, and up to 25% of them will not recover and suffer chronic neurocognitive impairments. The main pathology in these cases involves diffuse brain injuries, which are hard to detect by anatomical imaging yet noticeable in metabolic imaging. The current study tested the effectiveness of Hyperbaric Oxygen Therapy (HBOT) in improving brain function and quality of life in mTBI patients suffering chronic neurocognitive impairments. The trial population included 56 mTBI patients 1-5 years after injury with prolonged post-concussion syndrome (PCS). The HBOT effect was evaluated by means of prospective, randomized, crossover controlled trial: the patients were randomly assigned to treated or crossover groups.